Novo Nordisk Wins Another Legal Battle Against Compounding Of Wegovy, Ozempic: Retail’s Bullish
Friday, April 25, 2025
Tuesday, April 22, 2025
Thursday, April 17, 2025
Trump order seeks changes to Medicare drug price negotiation program, PBM reform
By Noah Tong
A new, healthcare-focused executive order from President Trump is wide-ranging and includes provisions on drug prices, PBM reform, 340B hospitals and more.
Friday, April 11, 2025
Wednesday, April 9, 2025
| Annovex Pharma, Inc. | Center for Drug Evaluation and Research (CDER) | Compounding Pharmacy/Adulterated Drug Products |
Tuesday, April 1, 2025
Tuesday, March 25, 2025
Friday, March 14, 2025
FDA Conditionally Approves Drug for Management of Ventricular Hypertrophy in Cats
Today, the U.S. Food and Drug Administration is announcing the conditional approval of Felycin-CA1 (sirolimus delayed-release tablets) for the management of ventricular hypertrophy in cats with subclinical hypertrophic cardiomyopathy (HCM). This is the first product approved for use in cats with HCM for any indication.
Cardiomyopathy is a disease of the heart muscle. HCM in cats causes thickening of the heart's left ventricle. It is the most common heart disease in cats and is one of the most common causes of death in cats. While the cause is unknown in most cases, HCM is associated with a genetic mutation in certain breeds, such as Maine Coons, Ragdolls, and Persians. HCM is a progressive disease. Cats in the subclinical phase have thickening of their heart wall but do not show clinical symptoms of the disease yet. Cats may live for years in the subclinical phase, while others may progress to congestive heart failure, arterial thromboembolism, or sudden death.
 |
Wednesday, March 12, 2025
| Elanco Animal Health | Center for Veterinary Medicine | False & Misleading Claims/Misbranded | |||
| Aurora Pharmaceutical | Center for Veterinary Medicine | False & Misleading Claims/Misbranded | |||
| Filler Lux dba Filler Lux USA | Center for Drug Evaluation and Research (CDER) | Unapproved New Drugs/Misbranded | |||
| Fox Pharma LLC | Center for Drug Evaluation and Research (CDER) | Unapproved New Drugs/Misbranded | |||
| Hyaluron Pen Store, LLC dba Glow Nest Beauty | Center for Drug Evaluation and Research (CDER) | Unapproved New Drugs/Misbranded |
| Aurora Pharmaceutical | Center for Veterinary Medicine | False & Misleading Claims/Misbranded | |||
| Shree Jaya Laboratories PVT. LTD. | Center for Drug Evaluation and Research (CDER) | CGMP/Active Pharmaceutical Ingredient (API)/Adulterated | |||
| C & A Naturistics | Center for Drug Evaluation and Research (CDER) | Unapproved New Drugs/Misbranded | |||
| USApeptide.com | Center for Drug Evaluation and Research (CDER) | Unapproved New Drugs/Misbrande |
Subscribe to:
Posts (Atom)